25 XP   0   0   10

Oncosil Medical Ltd
Buy, Hold or Sell?

Let's analyse Oncosil together

PenkeI guess you are interested in Oncosil Medical Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Oncosil Medical Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Oncosil Medical Ltd

I send you an email if I find something interesting about Oncosil Medical Ltd.

Quick analysis of Oncosil (30 sec.)










What can you expect buying and holding a share of Oncosil? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.00
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-40.9%

For what price can you sell your share?

Current Price per Share
A$0.01
Expected price per share
A$0.005 - A$0.0080405405405405
How sure are you?
50%

1. Valuation of Oncosil (5 min.)




Live pricePrice per Share (EOD)

A$0.01

Intrinsic Value Per Share

A$-0.08 - A$-0.04

Total Value Per Share

A$-0.07 - A$-0.03

2. Growth of Oncosil (5 min.)




Is Oncosil growing?

Current yearPrevious yearGrowGrow %
How rich?$6.3m$7.1m-$823.6k-13.0%

How much money is Oncosil making?

Current yearPrevious yearGrowGrow %
Making money-$7.2m-$6.8m-$395.8k-5.4%
Net Profit Margin-3,085.0%-4,627.8%--

How much money comes from the company's main activities?

3. Financial Health of Oncosil (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#250 / 339

Most Revenue
#294 / 339

Most Profit
#243 / 339

Most Efficient
#317 / 339

What can you expect buying and holding a share of Oncosil? (5 min.)

Welcome investor! Oncosil's management wants to use your money to grow the business. In return you get a share of Oncosil.

What can you expect buying and holding a share of Oncosil?

First you should know what it really means to hold a share of Oncosil. And how you can make/lose money.

Speculation

The Price per Share of Oncosil is A$0.006. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oncosil.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oncosil, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oncosil.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-58.1%0.00-58.1%0.00-54.9%0.00-46.4%0.00-38.6%
Usd Book Value Change Per Share0.00-6.6%0.00-6.6%0.00-2.7%0.00-8.5%0.002.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.0017.1%0.008.5%
Usd Total Gains Per Share0.00-6.6%0.00-6.6%0.00-2.7%0.008.6%0.0010.5%
Usd Price Per Share0.01-0.01-0.03-0.04-0.06-
Price to Earnings Ratio-2.34--2.34--8.26--19.05--35.97-
Price-to-Total Gains Ratio-20.71--20.71--166.12--40.97--15.41-
Price to Book Ratio2.69-2.69-7.94-8.65-16.35-
Price-to-Total Gains Ratio-20.71--20.71--166.12--40.97--15.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0038538
Number of shares259484
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (259484 shares)-102.23134.13
Gains per Year (259484 shares)-408.90536.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-409-4191064-528527
20-818-8282128-10551064
30-1227-12373193-15831601
40-1636-16464257-21112138
50-2045-20555321-26382675
60-2453-24646385-31663212
70-2862-28737449-36943749
80-3271-32828514-42214286
90-3680-36919578-47494823
100-4089-410010642-52775360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.019.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%9.010.00.047.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.09.010.0%1.00.018.05.3%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%9.010.00.047.4%

Fundamentals of Oncosil

About Oncosil Medical Ltd

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

Fundamental data was last updated by Penke on 2024-04-02 21:22:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Oncosil Medical Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Oncosil earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • A Net Profit Margin of -3,085.0% means that $-30.85 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oncosil Medical Ltd:

  • The MRQ is -3,085.0%. The company is making a huge loss. -2
  • The TTM is -3,085.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3,085.0%TTM-3,085.0%0.0%
TTM-3,085.0%YOY-4,627.8%+1,542.8%
TTM-3,085.0%5Y-2,577.2%-507.8%
5Y-2,577.2%10Y-1,480.5%-1,096.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,085.0%-11.2%-3,073.8%
TTM-3,085.0%-19.6%-3,065.4%
YOY-4,627.8%-14.4%-4,613.4%
5Y-2,577.2%-21.3%-2,555.9%
10Y-1,480.5%-24.8%-1,455.7%
1.1.2. Return on Assets

Shows how efficient Oncosil is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • -98.9% Return on Assets means that Oncosil generated $-0.99 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oncosil Medical Ltd:

  • The MRQ is -98.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -98.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-98.9%TTM-98.9%0.0%
TTM-98.9%YOY-82.1%-16.8%
TTM-98.9%5Y-62.5%-36.4%
5Y-62.5%10Y-51.8%-10.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-98.9%-4.0%-94.9%
TTM-98.9%-4.5%-94.4%
YOY-82.1%-4.8%-77.3%
5Y-62.5%-4.0%-58.5%
10Y-51.8%-4.9%-46.9%
1.1.3. Return on Equity

Shows how efficient Oncosil is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • -114.8% Return on Equity means Oncosil generated $-1.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oncosil Medical Ltd:

  • The MRQ is -114.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -114.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-114.8%TTM-114.8%0.0%
TTM-114.8%YOY-96.1%-18.7%
TTM-114.8%5Y-72.7%-42.1%
5Y-72.7%10Y-58.8%-13.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-114.8%-3.9%-110.9%
TTM-114.8%-5.6%-109.2%
YOY-96.1%-5.9%-90.2%
5Y-72.7%-6.1%-66.6%
10Y-58.8%-7.0%-51.8%

1.2. Operating Efficiency of Oncosil Medical Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oncosil is operating .

  • Measures how much profit Oncosil makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • An Operating Margin of -3,414.3% means the company generated $-34.14  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oncosil Medical Ltd:

  • The MRQ is -3,414.3%. The company is operating very inefficient. -2
  • The TTM is -3,414.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3,414.3%TTM-3,414.3%0.0%
TTM-3,414.3%YOY-4,922.3%+1,508.0%
TTM-3,414.3%5Y-2,875.9%-538.4%
5Y-2,875.9%10Y-1,685.9%-1,190.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,414.3%-24.1%-3,390.2%
TTM-3,414.3%-16.9%-3,397.4%
YOY-4,922.3%-13.4%-4,908.9%
5Y-2,875.9%-19.2%-2,856.7%
10Y-1,685.9%-24.0%-1,661.9%
1.2.2. Operating Ratio

Measures how efficient Oncosil is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 35.14 means that the operating costs are $35.14 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 35.143. The company is inefficient in keeping operating costs low. -1
  • The TTM is 35.143. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ35.143TTM35.1430.000
TTM35.143YOY50.223-15.080
TTM35.1435Y29.359+5.784
5Y29.35910Y17.159+12.200
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ35.1431.431+33.712
TTM35.1431.426+33.717
YOY50.2231.503+48.720
5Y29.3591.440+27.919
10Y17.1591.371+15.788

1.3. Liquidity of Oncosil Medical Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oncosil is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 7.16 means the company has $7.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 7.160. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.160. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.160TTM7.1600.000
TTM7.160YOY7.209-0.049
TTM7.1605Y8.704-1.545
5Y8.70410Y17.268-8.564
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1602.754+4.406
TTM7.1602.763+4.397
YOY7.2093.488+3.721
5Y8.7043.617+5.087
10Y17.2683.514+13.754
1.3.2. Quick Ratio

Measures if Oncosil is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • A Quick Ratio of 6.88 means the company can pay off $6.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 6.880. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.880. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.880TTM6.8800.000
TTM6.880YOY6.945-0.064
TTM6.8805Y8.589-1.709
5Y8.58910Y19.652-11.063
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8801.532+5.348
TTM6.8801.656+5.224
YOY6.9452.139+4.806
5Y8.5892.301+6.288
10Y19.6522.255+17.397

1.4. Solvency of Oncosil Medical Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oncosil assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oncosil to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.14 means that Oncosil assets are financed with 13.9% credit (debt) and the remaining percentage (100% - 13.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 0.139. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.139. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.139TTM0.1390.000
TTM0.139YOY0.146-0.007
TTM0.1395Y0.127+0.012
5Y0.12710Y0.100+0.027
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1390.389-0.250
TTM0.1390.386-0.247
YOY0.1460.338-0.192
5Y0.1270.442-0.315
10Y0.1000.460-0.360
1.4.2. Debt to Equity Ratio

Measures if Oncosil is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • A Debt to Equity ratio of 16.1% means that company has $0.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 0.161. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.161. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.161TTM0.1610.000
TTM0.161YOY0.171-0.010
TTM0.1615Y0.147+0.015
5Y0.14710Y0.114+0.033
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1610.559-0.398
TTM0.1610.560-0.399
YOY0.1710.478-0.307
5Y0.1470.624-0.477
10Y0.1140.674-0.560

2. Market Valuation of Oncosil Medical Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Oncosil generates.

  • Above 15 is considered overpriced but always compare Oncosil to the Medical Devices industry mean.
  • A PE ratio of -2.34 means the investor is paying $-2.34 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oncosil Medical Ltd:

  • The EOD is -1.106. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.341. Based on the earnings, the company is expensive. -2
  • The TTM is -2.341. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.106MRQ-2.341+1.235
MRQ-2.341TTM-2.3410.000
TTM-2.341YOY-8.264+5.923
TTM-2.3415Y-19.048+16.708
5Y-19.04810Y-35.974+16.925
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.106-0.997-0.109
MRQ-2.341-1.578-0.763
TTM-2.341-2.041-0.300
YOY-8.264-2.761-5.503
5Y-19.048-2.064-16.984
10Y-35.974-1.463-34.511
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oncosil Medical Ltd:

  • The EOD is -1.103. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.335. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.335. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.103MRQ-2.335+1.232
MRQ-2.335TTM-2.3350.000
TTM-2.335YOY-8.763+6.428
TTM-2.3355Y-1,595.392+1,593.057
5Y-1,595.39210Y-919.824-675.568
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.103-0.935-0.168
MRQ-2.335-1.489-0.846
TTM-2.335-2.994+0.659
YOY-8.763-6.238-2.525
5Y-1,595.392-4.771-1,590.621
10Y-919.824-4.736-915.088
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oncosil is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.69 means the investor is paying $2.69 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Oncosil Medical Ltd:

  • The EOD is 1.270. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.687. Based on the equity, the company is underpriced. +1
  • The TTM is 2.687. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.270MRQ2.687-1.418
MRQ2.687TTM2.6870.000
TTM2.687YOY7.941-5.254
TTM2.6875Y8.647-5.959
5Y8.64710Y16.345-7.699
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.2701.890-0.620
MRQ2.6872.379+0.308
TTM2.6872.458+0.229
YOY7.9413.214+4.727
5Y8.6473.833+4.814
10Y16.3454.173+12.172
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Oncosil Medical Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Oncosil Medical Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%0.000-58%-0.001+29%0.000-435%
Book Value Per Share--0.0050.0050%0.005-11%0.006-24%0.006-23%
Current Ratio--7.1607.1600%7.209-1%8.704-18%17.268-59%
Debt To Asset Ratio--0.1390.1390%0.146-5%0.127+10%0.100+39%
Debt To Equity Ratio--0.1610.1610%0.171-6%0.147+10%0.114+41%
Dividend Per Share----0%-0%0.002-100%0.001-100%
Eps---0.005-0.0050%-0.005-5%-0.004-20%-0.004-34%
Free Cash Flow Per Share---0.005-0.0050%-0.005-11%-0.003-39%-0.003-47%
Free Cash Flow To Equity Per Share---0.001-0.0010%0.000-49%0.002-148%0.002-143%
Gross Profit Margin--1.0111.0110%1.035-2%1.035-2%1.017-1%
Intrinsic Value_10Y_max---0.037--------
Intrinsic Value_10Y_min---0.076--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.006--------
Intrinsic Value_3Y_max---0.010--------
Intrinsic Value_3Y_min---0.019--------
Intrinsic Value_5Y_max---0.017--------
Intrinsic Value_5Y_min---0.034--------
Market Cap12544140.288-112%26551763.61026551763.6100%88645258.035-70%120800070.973-78%208107287.378-87%
Net Profit Margin---30.850-30.8500%-46.278+50%-25.772-16%-14.805-52%
Operating Margin---34.143-34.1430%-49.223+44%-28.759-16%-16.859-51%
Operating Ratio--35.14335.1430%50.223-30%29.359+20%17.159+105%
Pb Ratio1.270-112%2.6872.6870%7.941-66%8.647-69%16.345-84%
Pe Ratio-1.106+53%-2.341-2.3410%-8.264+253%-19.048+714%-35.974+1437%
Price Per Share0.006-112%0.0130.0130%0.042-70%0.058-78%0.100-87%
Price To Free Cash Flow Ratio-1.103+53%-2.335-2.3350%-8.763+275%-1595.392+68239%-919.824+39301%
Price To Total Gains Ratio-9.782+53%-20.706-20.7060%-166.123+702%-40.966+98%-15.413-26%
Quick Ratio--6.8806.8800%6.945-1%8.589-20%19.652-65%
Return On Assets---0.989-0.9890%-0.821-17%-0.625-37%-0.518-48%
Return On Equity---1.148-1.1480%-0.961-16%-0.727-37%-0.588-49%
Total Gains Per Share---0.001-0.0010%0.000-58%0.001-176%0.001-163%
Usd Book Value--6346240.6546346240.6540%7169882.498-11%8390519.052-24%8191762.400-23%
Usd Book Value Change Per Share--0.0000.0000%0.000-58%-0.001+29%0.000-435%
Usd Book Value Per Share--0.0030.0030%0.003-11%0.004-24%0.004-23%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Eps---0.003-0.0030%-0.003-5%-0.003-20%-0.002-34%
Usd Free Cash Flow---7305168.862-7305168.8620%-6497513.223-11%-4476894.202-39%-3895802.695-47%
Usd Free Cash Flow Per Share---0.003-0.0030%-0.003-11%-0.002-39%-0.002-47%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%0.000-49%0.001-148%0.001-143%
Usd Market Cap8057101.307-112%17054197.76617054197.7660%56936849.236-70%77589885.586-78%133667310.683-87%
Usd Price Per Share0.004-112%0.0080.0080%0.027-70%0.037-78%0.064-87%
Usd Profit---7285561.370-7285561.3700%-6889761.337-5%-5324424.981-27%-4423421.764-39%
Usd Revenue--236158.937236158.9370%148878.075+59%951443.101-75%1490237.419-84%
Usd Total Gains Per Share--0.0000.0000%0.000-58%0.001-176%0.001-163%
 EOD+3 -5MRQTTM+0 -0YOY+9 -255Y+5 -3110Y+2 -34

4.2. Fundamental Score

Let's check the fundamental score of Oncosil Medical Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.106
Price to Book Ratio (EOD)Between0-11.270
Net Profit Margin (MRQ)Greater than0-30.850
Operating Margin (MRQ)Greater than0-34.143
Quick Ratio (MRQ)Greater than16.880
Current Ratio (MRQ)Greater than17.160
Debt to Asset Ratio (MRQ)Less than10.139
Debt to Equity Ratio (MRQ)Less than10.161
Return on Equity (MRQ)Greater than0.15-1.148
Return on Assets (MRQ)Greater than0.05-0.989
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Oncosil Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.346
Ma 20Greater thanMa 500.006
Ma 50Greater thanMa 1000.007
Ma 100Greater thanMa 2000.008
OpenGreater thanClose0.006
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets11,474
Total Liabilities1,594
Total Stockholder Equity9,880
 As reported
Total Liabilities 1,594
Total Stockholder Equity+ 9,880
Total Assets = 11,474

Assets

Total Assets11,474
Total Current Assets11,235
Long-term Assets239
Total Current Assets
Cash And Cash Equivalents 9,394
Short-term Investments 117
Net Receivables 1,286
Other Current Assets 555
Total Current Assets  (as reported)11,235
Total Current Assets  (calculated)11,352
+/- 117
Long-term Assets
Property Plant Equipment 239
Long-term Assets  (as reported)239
Long-term Assets  (calculated)239
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,569
Long-term Liabilities25
Total Stockholder Equity9,880
Total Current Liabilities
Short-term Debt 146
Accounts payable 960
Other Current Liabilities 463
Total Current Liabilities  (as reported)1,569
Total Current Liabilities  (calculated)1,569
+/-0
Long-term Liabilities
Long term Debt Total 25
Long-term Liabilities  (as reported)25
Long-term Liabilities  (calculated)25
+/- 0
Total Stockholder Equity
Common Stock86,507
Retained Earnings -84,368
Accumulated Other Comprehensive Income 7,741
Other Stockholders Equity 0
Total Stockholder Equity (as reported)9,880
Total Stockholder Equity (calculated)9,880
+/-0
Other
Capital Stock86,507
Cash and Short Term Investments 9,394
Common Stock Shares Outstanding 1,196,040
Current Deferred Revenue-146
Liabilities and Stockholders Equity 11,474
Net Debt -9,223
Net Invested Capital 9,880
Net Tangible Assets 9,880
Net Working Capital 9,666
Property Plant and Equipment Gross 584
Short Long Term Debt Total 171



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-30
> Total Assets 
947
8,185
7,002
6,167
5,228
2,959
3,030
2,524
6,244
12,281
7,407
15,897
11,805
19,882
11,668
24,060
14,150
13,069
11,474
11,47413,06914,15024,06011,66819,88211,80515,8977,40712,2816,2442,5243,0302,9595,2286,1677,0028,185947
   > Total Current Assets 
918
3,447
2,538
2,296
1,988
1,919
3,030
2,521
3,592
9,617
7,352
15,805
11,689
19,796
11,606
23,921
13,620
12,745
11,235
11,23512,74513,62023,92111,60619,79611,68915,8057,3529,6173,5922,5213,0301,9191,9882,2962,5383,447918
       Cash And Cash Equivalents 
887
2,821
1,901
1,746
1,395
1,552
2,727
2,412
3,511
2,739
2,523
9,780
8,001
15,205
7,689
20,998
12,240
11,280
9,394
9,39411,28012,24020,9987,68915,2058,0019,7802,5232,7393,5112,4122,7271,5521,3951,7461,9012,821887
       Short-term Investments 
0
0
0
0
0
0
141
80
57
4,350
3,598
3,259
0
0
69
69
91
89
117
11789916969003,2593,5984,3505780141000000
       Net Receivables 
0
611
608
534
499
332
134
5
14
137
75
2,628
3,529
4,483
3,819
2,806
1,181
908
1,286
1,2869081,1812,8063,8194,4833,5292,628751371451343324995346086110
       Other Current Assets 
31
14
29
15
95
35
27
25
10
2,391
1,157
138
159
108
69
118
198
557
555
555557198118691081591381,1572,391102527359515291431
   > Long-term Assets 
28
4,738
4,464
3,871
3,240
1,040
0
2
2,651
2,664
55
92
115
86
62
138
531
325
239
239325531138628611592552,6642,651201,0403,2403,8714,4644,73828
       Property Plant Equipment 
3
1,078
804
520
254
140
0
2
4
17
55
92
115
86
62
138
531
325
239
23932553113862861159255174201402545208041,0783
       Goodwill 
0
1,841
1,841
1,841
1,841
900
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000009001,8411,8411,8411,8410
       Intangible Assets 
0
1,818
1,818
1,510
1,144
900
0
0
2,648
2,648
0
0
0
0
0
0
0
0
0
0000000002,6482,648009001,1441,5101,8181,8180
       Other Assets 
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0000000003000000000
> Total Liabilities 
47
2,727
2,322
2,080
946
381
117
41
193
121
446
1,086
1,670
1,728
993
2,159
2,454
1,907
1,594
1,5941,9072,4542,1599931,7281,6701,086446121193411173819462,0802,3222,72747
   > Total Current Liabilities 
47
1,367
1,391
1,495
471
347
117
41
193
121
446
1,086
1,670
1,728
993
2,159
2,133
1,768
1,569
1,5691,7682,1332,1599931,7281,6701,086446121193411173474711,4951,3911,36747
       Short-term Debt 
0
214
180
149
0
0
141
80
57
4,350
3,598
3,259
0
0
110
110
163
165
146
146165163110110003,2593,5984,3505780141001491802140
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
0
0
0
00027000000000000000
       Accounts payable 
0
512
645
744
175
83
105
7
54
36
171
217
901
857
364
1,356
1,227
931
960
9609311,2271,35636485790121717136547105831757446455120
       Other Current Liabilities 
6
590
531
575
218
187
12
34
139
84
275
870
769
871
629
693
743
671
463
4636717436936298717698702758413934121872185755315906
   > Long-term Liabilities 
0
1,361
931
585
475
34
0
0
0
0
0
0
0
0
364
321
321
139
25
2513932132136400000000344755859311,3610
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
321
139
25
251393210000000000000000
       Other Liabilities 
0
412
188
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
00000000030000001884120
> Total Stockholder Equity
900
5,457
4,680
4,087
4,282
2,578
2,913
2,483
6,051
12,160
6,961
14,811
10,135
18,155
10,675
21,901
11,696
11,163
9,880
9,88011,16311,69621,90110,67518,15510,13514,8116,96112,1606,0512,4832,9132,5784,2824,0874,6805,457900
   Common Stock
926
5,567
6,366
8,508
8,508
8,695
9,708
9,709
13,889
23,786
23,806
35,695
36,645
52,257
52,257
70,137
70,397
79,910
86,507
86,50779,91070,39770,13752,25752,25736,64535,69523,80623,78613,8899,7099,7088,6958,5088,5086,3665,567926
   Retained Earnings -84,368-73,025-62,298-51,864-47,602-39,036-30,496-23,480-18,712-13,183-8,960-8,081-7,650-6,192-4,480-4,596-1,829-155-26
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
1,558
1,867
2,596
3,986
4,933
6,020
-18,273
-8,099
-6,885
0
0-6,885-8,099-18,2736,0204,9333,9862,5961,8671,558000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue368
Cost of Revenue-6,862
Gross Profit-6,494-6,494
 
Operating Income (+$)
Gross Profit-6,494
Operating Expense-6,059
Operating Income-12,554-12,554
 
Operating Expense (+$)
Research Development2,851
Selling General Administrative3,052
Selling And Marketing Expenses130
Operating Expense6,0596,034
 
Net Interest Income (+$)
Interest Income70
Interest Expense-11
Other Finance Cost-7
Net Interest Income52
 
Pretax Income (+$)
Operating Income-12,554
Net Interest Income52
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-12,443-12,664
EBIT - interestExpense = -12,564
-12,443
-11,332
Interest Expense11
Earnings Before Interest and Taxes (EBIT)-12,554-12,432
Earnings Before Interest and Taxes (EBITDA)-12,378
 
After tax Income (+$)
Income Before Tax-12,443
Tax Provision-0
Net Income From Continuing Ops-11,343-12,443
Net Income-11,343
Net Income Applicable To Common Shares-11,343
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses12,921
Total Other Income/Expenses Net111-52
 

Technical Analysis of Oncosil
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oncosil. The general trend of Oncosil is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oncosil's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oncosil Medical Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.007 < 0.0080405405405405 < 0.0080405405405405.

The bearish price targets are: 0.005 > 0.005 > 0.005.

Tweet this
Oncosil Medical Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oncosil Medical Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oncosil Medical Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oncosil Medical Ltd. The current macd is -0.000097.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Oncosil price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Oncosil. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Oncosil price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Oncosil Medical Ltd Daily Moving Average Convergence/Divergence (MACD) ChartOncosil Medical Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oncosil Medical Ltd. The current adx is 22.90.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Oncosil shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Oncosil Medical Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oncosil Medical Ltd. The current sar is 0.0050792.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Oncosil Medical Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oncosil Medical Ltd. The current rsi is 46.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Oncosil Medical Ltd Daily Relative Strength Index (RSI) ChartOncosil Medical Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oncosil Medical Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -3/(-6 +6).

  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oncosil price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Oncosil Medical Ltd Daily Stochastic Oscillator ChartOncosil Medical Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oncosil Medical Ltd. The current cci is 25.98.

Oncosil Medical Ltd Daily Commodity Channel Index (CCI) ChartOncosil Medical Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oncosil Medical Ltd. The current cmo is -8.59197028.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Oncosil Medical Ltd Daily Chande Momentum Oscillator (CMO) ChartOncosil Medical Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oncosil Medical Ltd. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Oncosil is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Oncosil Medical Ltd Daily Williams %R ChartOncosil Medical Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Oncosil Medical Ltd.

Oncosil Medical Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oncosil Medical Ltd. The current atr is 0.00089966.

Oncosil Medical Ltd Daily Average True Range (ATR) ChartOncosil Medical Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oncosil Medical Ltd. The current obv is -101,832,890.

Oncosil Medical Ltd Daily On-Balance Volume (OBV) ChartOncosil Medical Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oncosil Medical Ltd. The current mfi is 71.33.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Oncosil Medical Ltd Daily Money Flow Index (MFI) ChartOncosil Medical Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oncosil Medical Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Oncosil Medical Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oncosil Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.346
Ma 20Greater thanMa 500.006
Ma 50Greater thanMa 1000.007
Ma 100Greater thanMa 2000.008
OpenGreater thanClose0.006
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Oncosil with someone you think should read this too:
  • Are you bullish or bearish on Oncosil? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oncosil? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oncosil Medical Ltd

I send you an email if I find something interesting about Oncosil Medical Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Oncosil Medical Ltd.

Receive notifications about Oncosil Medical Ltd in your mailbox!